Literature DB >> 26148262

Miles to Go on the SCENIC Route: Should Chromoendoscopy Become the Standard of Care in IBD Surveillance?

Peter D R Higgins1.   

Abstract

The recent SCENIC Consensus statement has raised questions about which patients with chronic colitis should receive chromoendoscopic surveillance. Two papers in this issue of the American Journal of Gastroenterology provide more evidence and context, and this editorial discusses the current evidence base, which patients might benefit from chromoendoscopy, and what more evidence is needed before chromoendoscopy can be considered a possible new standard of care in all patients with chronic colitis.

Entities:  

Mesh:

Year:  2015        PMID: 26148262     DOI: 10.1038/ajg.2015.179

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

Review 1.  Overdiagnosis in cancer.

Authors:  H Gilbert Welch; William C Black
Journal:  J Natl Cancer Inst       Date:  2010-04-22       Impact factor: 13.506

2.  Spontaneous regression of localized neuroblastoma detected by mass screening.

Authors:  K Yamamoto; R Hanada; A Kikuchi; M Ichikawa; T Aihara; E Oguma; T Moritani; Y Shimanuki; M Tanimura; Y Hayashi
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

3.  The SCENIC consensus statement on surveillance and management of dysplasia in inflammatory bowel disease: praise and words of caution.

Authors:  James F Marion; Bruce E Sands
Journal:  Gastroenterology       Date:  2015-03       Impact factor: 22.682

4.  SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease.

Authors:  Loren Laine; Tonya Kaltenbach; Alan Barkun; Kenneth R McQuaid; Venkataraman Subramanian; Roy Soetikno
Journal:  Gastroenterology       Date:  2015-03       Impact factor: 22.682

5.  Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.

Authors:  E Mooiweer; A E van der Meulen-de Jong; C Y Ponsioen; H H Fidder; P D Siersema; E Dekker; B Oldenburg
Journal:  Am J Gastroenterol       Date:  2015-03-31       Impact factor: 10.864

6.  Cost implications and complications of overtreatment of low-risk prostate cancer in the United States.

Authors:  Ayal A Aizer; Xiangmei Gu; Ming-Hui Chen; Toni K Choueiri; Neil E Martin; Jason A Efstathiou; Andrew S Hyatt; Powell L Graham; Quoc-Dien Trinh; Jim C Hu; Paul L Nguyen
Journal:  J Natl Compr Canc Netw       Date:  2015-01       Impact factor: 11.908

7.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

8.  Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview.

Authors:  Chang-Ho Ryan Choi; Matthew D Rutter; Alan Askari; Gui Han Lee; Janindra Warusavitarne; Morgan Moorghen; Siwan Thomas-Gibson; Brian P Saunders; Trevor A Graham; Ailsa L Hart
Journal:  Am J Gastroenterol       Date:  2015-03-31       Impact factor: 10.864

  8 in total
  6 in total

1.  Response to Editorial of Peter D.R. Higgins (July 2015).

Authors:  Loren Laine; Tonya Kaltenbach; Alan Barkun; Kenneth R McQuaid; Venkataraman Subramanian; Roy Soetikno
Journal:  Am J Gastroenterol       Date:  2015-12       Impact factor: 10.864

Review 2.  An Update on Surveillance in Ulcerative Colitis.

Authors:  Jimmy K Limdi; Francis A Farraye
Journal:  Curr Gastroenterol Rep       Date:  2018-03-07

3.  Advanced imaging in colonoscopy: contemporary approach to dysplasia surveillance in inflammatory bowel disease.

Authors:  Iosif Beintaris; Matt Rutter
Journal:  Frontline Gastroenterol       Date:  2016-08-23

4.  Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis.

Authors:  John B Kisiel; Gauree G Konijeti; Andrew J Piscitello; Tarun Chandra; Thomas F Goss; David A Ahlquist; Francis A Farraye; Ashwin N Ananthakrishnan
Journal:  Clin Gastroenterol Hepatol       Date:  2016-07-25       Impact factor: 11.382

5.  Colonoscopy Surveillance and Management of Dysplasia in Inflammatory Bowel Disease.

Authors:  Tonya Kaltenbach; Gisele Leite; Roy Soetikno
Journal:  Curr Treat Options Gastroenterol       Date:  2016-03

Review 6.  Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand?

Authors:  Michail Galanopoulos; Emmanouela Tsoukali; Filippos Gkeros; Marina Vraka; Georgios Karampekos; Gerassimos J Matzaris
Journal:  World J Gastrointest Endosc       Date:  2018-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.